Silybi mariani fructuum extract+Phospholipides (active substance) - analogs
Components: Silybi mariani fructuum extract || Phospholipides |
|||||||||
Pharmgroups: Hepatoprotectors in combinations |
|||||||||
Prices in pharmacies: Instructions Silybi mariani fructuum extract+Phospholipides | |||||||||
|
ⓘ✘Enter drugs for checking interactions through a quick button search . |
|
ⓘ✘ diseases to evaluate contraindications and side effects through a quick search. |
Начиная работу с сервисом, вы принимаете соглашение пользователя. Kiberis do not replace the doctor!
Silybi mariani fructuum extract+Phospholipides included in the composition |
Prices in pharmacies |
Phosphonciale | 4-11.8€ |
-
Similar
Prices in
pharmaciesAnalogs by action ⓘ✘Analogues of the drug according to its degree of similarity with other drugs that are not direct analogues
- 90% Glycyrrhizic acid+Phospholipides [Phospholipides and more 1Glycyrrhizinic acid]
- 87% Methionine+Phospholipids [Methionine and more 1Phospholipides]
- 86% Multivitamins+Phospholipides [Multivitamins and more 1Phospholipides]
- 72% Dymyanka herbal extract+Milk Thistle fruit extract [Silybi mariani fructuum extract]
- 65% Bacterial lysates [Phospholipides and more 1Glycyrrhizinic acid]
- 55% Phospholipides
- 45% Inosine+Meglumine+Methionine+Nicotinamide+Succinic acid* [Inosine and more 4Meglumine, Methionine, Nicotinamide, Succinic acid]
- 40% Arginine glutamate
- 39% Glutamyl-Cysteinyl-Glycine disodium
- 37% Betulae foliorum extract+Hyperici perforati herbae extract+Silybi mariani fructuum extract+Tanaceti floridis extract [Betulae folia and more 3Hyperici perforati herbae extract, Silybi mariani fructuum extract, Tanaceti floridis extract]
- 36% Inosine
- 35% Morpholinium-methyl-thiazolyl-thioacetate
- 34% Low molecular weight sugars
- 32% Deanol aceglumate
- 30% Silybi mariani fructuum extract
- 28% Silybi mariani fructuum extract+Bifidobacterinum bifidum+Lactobacterium fermentum [Silybi mariani fructuum extract and more 2Bifidobacterium bifidum, Lactobacteries]
- 26% Vaccine hepatitis A
- 25% Ademetionine
- 25% 1-(4-bromphenyl)violuric acid
- 25% Heparin sodium+Phospholipids+Aescin [Heparin sodium and more 2Aescin, Phospholipides]
- 24% Aescin+Essencial phospholipids+Heparin sodium [Aescin and more 2Heparin sodium, Phospholipides]
- 22% Adenosine phosphate
- 21% Vaccine hepatitis A and B [Vaccine hepatitis A and more 1Vaccine hepatitis B]
- 20% Interferon alfa-2
- 20% Piracetam+Thiotriazoline [Piracetam and more 1Morpholinium-methyl-thiazolyl-thioacetate]
- 19% Interferon alfa-2a
- 19% Interferon alfa-2b human recombinant
- 18% Dioxomethyltetrahydropyrimidine
- 18% Interferon gamma human recombinant
- 18% Azathioprine
- 18% Morpholinium-methyl-thiazolyl-thioacetate+Piracetam [Morpholinium-methyl-thiazolyl-thioacetate and more 1Piracetam]
- 18% Cocarboxylase
- 18% Pyridoxalphosphate
- 17% Ascorbic acid
- 17% Thioctic acid
- 17% Fructose
- 17% Aloe tree leaf extract+Ascorbic acid [Ascorbic acid]
- 16% Calcium gluconate
- 16% Arginil-alfa-aspartil-lysil-valil-tyrosil-arginine
- 15% Thiamine
- 15% Cyanocobalamin
- 15% Vitamin E
- 15% Menadione sodium bisulfite
- 15% Belladonna
- 15% Benfotiamine+Pyridoxine [Benfotiamine and more 1Pyridoxine]
- 15% Ascorbic acid+Dextose+Sacharose [Ascorbic acid and more 1Dextrose]
- 14% Cynarae scomuli foliae extract
- 14% Calcium chloride
- 14% Calcium pangamate
- 14% Rosae pingue fructuum extract+Ascorbic Acid [Rosae pingue fructuum extract and more 1Ascorbic acid]
Learn more about the selection of analogues
- The drug has «Silybi mariani fructuum extract+Phospholipides» 51 analog by action, the most similar - Glycyrrhizic acid+Phospholipides .
- Medical online service has selected the best substitutes for Silybi mariani fructuum extract+Phospholipides based on its instructions, components, pharmaceutical groups and practical application.
- The table shows the prices of analogues Silybi mariani fructuum extract+Phospholipides to choose the cheapest pills.
- If you have introduced other drugs for registration, substitutes are selected taking into account the assessment of interactions and safety.
- Sometimes, due to the presence of dangerous interactions, it is necessary to use drugs that are similar in effect, sometimes even from different pharmacological groups.